What we know about prostaglandin pathway dysfunction in chronic enteropathies: From endoscopy to molecular diagnosis

In: Journal of Translational Internal Medicine · 2026 · vol. 14(2) , pp. 204–224 · doi:10.1515/jtim-2026-0020 · PMID:42046811 · W7140888309
article OA: hybrid CC0
AI-generated summary by claude@2026-06, 2026-06-13

This review details prostaglandin pathway dysfunction in chronic enteropathies, exploring its molecular connections and potential therapeutic avenues for improved clinical management.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

). By unraveling molecular connections and highlighting innovative therapeutic avenues, we aim to advance clinical management and improve the well-being and quality of life for patients with PGAE.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

References (100)

Source provenance

openalex
last seen: 2026-05-13T19:41:21.799026+00:00
License: CC0 · commercial use OK